Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
Clinical trial NCT05191706 · RECRUITING
Trial details
- NCT number
- NCT05191706
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-04
- Primary completion
- 2026-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.